miR-211通过DUSP6-ERK5轴促进BRAFV600E黑色素瘤生长及BRAF/MEK抑制剂耐药
该研究在BRAFV600E突变黑色素瘤细胞中探讨miR-211的作用:miR-211在体内促进移植瘤侵袭性生长,通过转录后激活ERK5信号促进增殖;miR-211表达还增加细胞对vemurafenib和cobimetinib的耐药性,且耐药与ERK5磷酸化升高相关;机制上miR-211直接抑制ERK5通路特异性磷酸酶DUSP6的表达。
要点
- miR-211在体内促进BRAFV600E突变黑色素瘤移植瘤的侵袭性生长。
- miR-211通过抑制DUSP6激活ERK5信号,促进肿瘤增殖。
- miR-211表达升高与BRAF/MEK抑制剂耐药相关,提示该轴为潜在干预靶点。
核心结论
- miR-211通过直接抑制DUSP6激活ERK5信号,促进BRAFV600E突变黑色素瘤体内生长,并增加对BRAF和MEK抑制剂的耐药性。
研究设计与样本
- 在BRAFV600E突变黑色素瘤细胞及体内移植瘤模型中研究miR-211的功能与机制。
主要发现
- miR-211表达促进BRAFV600E突变黑色素瘤移植瘤的侵袭性生长。
- miR-211通过转录后激活ERK5信号促进细胞增殖。
- miR-211表达增加黑色素瘤细胞对vemurafenib和cobimetinib的耐药性,并与ERK5磷酸化升高相关。
- miR-211直接抑制ERK5通路特异性磷酸酶DUSP6的表达,DUSP6为miR-211靶基因。
临床怎么用
- 提示miR-211-DUSP6-ERK5轴可作为克服BRAF/MEK抑制剂耐药的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MicroRNAs (miRs) are important posttranscriptional regulators of cell fate in both normal and disease states. miR-211 has previously been shown to be a direct regulator of metabolism in BRAFV600E-mutant melanoma cells in vitro. Here, we report that miR-211 expression promotes the aggressive growth of BRAFV600E-mutant melanoma xenografts in vivo. miR-211 promoted proliferation through the posttranscriptional activation of extracellular signal-regulated kinase (ERK) 5 signaling, which has recently been implicated in the resistance to BRAF and MAPK/ERK kinase inhibitors. We therefore examined whether miR-211 similarly modulated melanoma resistance to the BRAF inhibitor vemurafenib and the MAPK/ERK kinase inhibitor cobimetinib. Consistent with this model, miR-211 expression increased melanoma cell resistance to both the inhibitors, and this resistance was associated with an increased ERK5 phosphorylation. miR-211 mediates these effects by directly inhibiting the expression of DUSP6, an ERK5 pathway-specific phosphatase and now shown to be an miR-211 target gene. These results dissect the role of the miR-211-DUSP6-ERK5 axis in melanoma tumor growth and suggest a mechanism for the development of drug-resistant tumors and a target for overcoming resistance.
引用
- Lee B, Sahoo A, Sawada J, et al. MicroRNA-211 Modulates the DUSP6-ERK5 Signaling Axis to Promote BRAFV600E-Driven Melanoma Growth In Vivo and BRAF/MEK Inhibitor Resistance. J Invest Dermatol. 2020. PMID: 32888955. doi:10.1016/j.jid.2020.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。